Logo image of MDB

MONGODB INC (MDB) Stock Fundamental Analysis

NASDAQ:MDB - Nasdaq - US60937P1066 - Common Stock - Currency: USD

174.81  +3.17 (+1.85%)

Fundamental Rating

4

Taking everything into account, MDB scores 4 out of 10 in our fundamental rating. MDB was compared to 82 industry peers in the IT Services industry. No worries on liquidiy or solvency for MDB as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, MDB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

MDB had positive earnings in the past year.
MDB had a positive operating cash flow in the past year.
MDB had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MDB reported negative operating cash flow in multiple years.
MDB Yearly Net Income VS EBIT VS OCF VS FCFMDB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M -200M -300M

1.2 Ratios

MDB has a Return On Assets of -3.76%. This is in the lower half of the industry: MDB underperforms 62.20% of its industry peers.
With a Return On Equity value of -4.64%, MDB perfoms like the industry average, outperforming 42.68% of the companies in the same industry.
Industry RankSector Rank
ROA -3.76%
ROE -4.64%
ROIC N/A
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MDB Yearly ROA, ROE, ROICMDB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20K 40K 60K 80K

1.3 Margins

The Gross Margin of MDB (73.32%) is better than 90.24% of its industry peers.
MDB's Gross Margin has been stable in the last couple of years.
MDB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
MDB Yearly Profit, Operating, Gross MarginsMDB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

More info and screens

8

2. Health

2.1 Basic Checks

MDB does not have a ROIC to compare to the WACC, probably because it is not profitable.
MDB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MDB has been increased compared to 5 years ago.
The debt/assets ratio for MDB has been reduced compared to a year ago.
MDB Yearly Shares OutstandingMDB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MDB Yearly Total Debt VS Total AssetsMDB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

MDB has an Altman-Z score of 13.35. This indicates that MDB is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 13.35, MDB belongs to the top of the industry, outperforming 95.12% of the companies in the same industry.
The Debt to FCF ratio of MDB is 0.31, which is an excellent value as it means it would take MDB, only 0.31 years of fcf income to pay off all of its debts.
MDB's Debt to FCF ratio of 0.31 is amongst the best of the industry. MDB outperforms 87.80% of its industry peers.
MDB has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.01, MDB belongs to the top of the industry, outperforming 82.93% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.31
Altman-Z 13.35
ROIC/WACCN/A
WACC8.89%
MDB Yearly LT Debt VS Equity VS FCFMDB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

MDB has a Current Ratio of 5.20. This indicates that MDB is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MDB (5.20) is better than 93.90% of its industry peers.
MDB has a Quick Ratio of 5.20. This indicates that MDB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 5.20, MDB belongs to the top of the industry, outperforming 93.90% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.2
Quick Ratio 5.2
MDB Yearly Current Assets VS Current LiabilitesMDB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.27% over the past year.
MDB shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 19.22%.
MDB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.61% yearly.
EPS 1Y (TTM)10.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
Revenue 1Y (TTM)19.22%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%19.74%

3.2 Future

Based on estimates for the next years, MDB will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.49% on average per year.
Based on estimates for the next years, MDB will show a quite strong growth in Revenue. The Revenue will grow by 16.55% on average per year.
EPS Next Y-27.98%
EPS Next 2Y-2.87%
EPS Next 3Y8.32%
EPS Next 5Y17.49%
Revenue Next Year14.97%
Revenue Next 2Y15.8%
Revenue Next 3Y16.6%
Revenue Next 5Y16.55%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
MDB Yearly Revenue VS EstimatesMDB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B
MDB Yearly EPS VS EstimatesMDB Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 47.89, MDB can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of MDB is on the same level as its industry peers.
When comparing the Price/Earnings ratio of MDB to the average of the S&P500 Index (28.18), we can say MDB is valued expensively.
A Price/Forward Earnings ratio of 66.50 indicates a quite expensive valuation of MDB.
The rest of the industry has a similar Price/Forward Earnings ratio as MDB.
When comparing the Price/Forward Earnings ratio of MDB to the average of the S&P500 Index (20.81), we can say MDB is valued expensively.
Industry RankSector Rank
PE 47.89
Fwd PE 66.5
MDB Price Earnings VS Forward Price EarningsMDB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

MDB's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 117.65
EV/EBITDA N/A
MDB Per share dataMDB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.87%
EPS Next 3Y8.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MDB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONGODB INC

NASDAQ:MDB (5/5/2025, 1:07:23 PM)

174.81

+3.17 (+1.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-05 2025-03-05/amc
Earnings (Next)06-04 2025-06-04/amc
Inst Owners92.88%
Inst Owner Change-1.56%
Ins Owners0.77%
Ins Owner Change2.12%
Market Cap14.19B
Analysts80
Price Target289.6 (65.67%)
Short Float %4.8%
Short Ratio1.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)78.84%
Min EPS beat(2)66.15%
Max EPS beat(2)91.53%
EPS beat(4)4
Avg EPS beat(4)56.31%
Min EPS beat(4)27.24%
Max EPS beat(4)91.53%
EPS beat(8)8
Avg EPS beat(8)86.45%
EPS beat(12)12
Avg EPS beat(12)163.56%
EPS beat(16)16
Avg EPS beat(16)137.13%
Revenue beat(2)2
Avg Revenue beat(2)4.9%
Min Revenue beat(2)4.5%
Max Revenue beat(2)5.3%
Revenue beat(4)4
Avg Revenue beat(4)3.31%
Min Revenue beat(4)1.47%
Max Revenue beat(4)5.3%
Revenue beat(8)8
Avg Revenue beat(8)4.48%
Revenue beat(12)12
Avg Revenue beat(12)5.29%
Revenue beat(16)16
Avg Revenue beat(16)5.92%
PT rev (1m)-7.57%
PT rev (3m)-22.53%
EPS NQ rev (1m)-0.16%
EPS NQ rev (3m)6.35%
EPS NY rev (1m)0.74%
EPS NY rev (3m)-22%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)0.14%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-2.21%
Valuation
Industry RankSector Rank
PE 47.89
Fwd PE 66.5
P/S 7.07
P/FCF 117.65
P/OCF 94.5
P/B 5.1
P/tB 5.28
EV/EBITDA N/A
EPS(TTM)3.65
EY2.09%
EPS(NY)2.63
Fwd EY1.5%
FCF(TTM)1.49
FCFY0.85%
OCF(TTM)1.85
OCFY1.06%
SpS24.71
BVpS34.27
TBVpS33.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.76%
ROE -4.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.32%
FCFM 6.01%
ROA(3y)-7.75%
ROA(5y)-10.95%
ROE(3y)-22.62%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.41%
GM growth 5Y0.85%
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.31
Debt/EBITDA N/A
Cap/Depr 187.92%
Cap/Sales 1.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.2
Quick Ratio 5.2
Altman-Z 13.35
F-Score5
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)83.49%
Cap/Depr(5y)72.21%
Cap/Sales(3y)0.8%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%48.84%
EPS Next Y-27.98%
EPS Next 2Y-2.87%
EPS Next 3Y8.32%
EPS Next 5Y17.49%
Revenue 1Y (TTM)19.22%
Revenue growth 3Y31.93%
Revenue growth 5Y36.61%
Sales Q2Q%19.74%
Revenue Next Year14.97%
Revenue Next 2Y15.8%
Revenue Next 3Y16.6%
Revenue Next 5Y16.55%
EBIT growth 1Y7.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3.48%
EBIT Next 3Y25.1%
EBIT Next 5Y36.16%
FCF growth 1Y4.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.64%
OCF growth 3Y178.14%
OCF growth 5YN/A